The growth and profitability of the U.S. molecular diagnostic testing market
continues to accelerate, making it the most desirable area of the United States'
$58.8 billion clinical laboratory industry.
If your lab is already committed to molecular diagnostic testing, this report
gives you detailed data and analysis and expert insight that will help you identify
and seize new opportunities, give you the inside story on how leading molecular
labs are expanding, and guide you in your strategic planning in the coming years.
And if you're still considering molecular diagnostic testing, you'll get the
basics of how to make the molecular diagnostic test decision, and how to set
up and run a molecular diagnostics lab.
Special Benefit: With this new edition, you have access to
the exclusive results of Washington G-2 Reports Advisory Services’ 2008 Molecular
Diagnostics Survey, which provides you with key demographics and new data on
budget and costs, advice for building your test menu, how others have made the
molecular diagnostic decision, and more.
This new 2009 edition also brings you the expert advice of 12 top molecular
diagnostics experts, and covers:
- The size, structure and outlook for the molecular diagnostics market
- Integrating molecular diagnostics into your lab
- The platform revolution and the move to fully automated platforms
- Regulations, pricing and reimbursement
- Business and financial strategies for molecular diagnostic labs
You also receive extensive appendices, including the top 100 molecular diagnostic
labs; labs offering molecular diagnostic tests by test volumes; profiles of
leading labs; and FDA-approved molecular diagnostic tests.
Preview this report's Table of Contents.
